| Cyber reporter kept fellow investors informed during Hemispherx meeting | | Print | |
| Written by M.E.Garza | ||||||||||||||||||||
| Thursday, 25 June 2009 18:12 | ||||||||||||||||||||
|
Employing his on-line alias, "StarmanDSS," Adams was able to provide fellow investors on social media forums like the YahooFinance boards with a much anticipated trickle of information that helped soothe nerves, kill rumors and ultimately gave many investors renewed confidence in the company. As of this moment, the company, it's shareholders and CFS patients continue to anxiously await a long delayed FDA's decision to clear Ampligen(R) as a treatment for Chronic Fatigue Syndrome.Shares of Hemispherx Biopharma traded up almost 20% and the company was among the biggest gainers in healthcare on Thursday. Below is an audio interview full of information and intelligence that might not otherwise be available elsewhere to HEB investors. In it, Mr. Adams shares with us an inside look at what transpired in Philadelphia on Wednesday.
Disclosure: Adams is long HEB BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites           
Set as favorite
Bookmark
Email this
Trackback(0)
Comments (9)
SK
said:
|
TrackBack URI for this entry
Subscribe to this comment's feed|
... Starman - paleeze come join us at MyStockBuddy.com! YOU ROCK! BioMedReports - I'm quoting you, I'm hyperlinking you... thanks so much for keeping this all in check. |
|
Casper2769
said:
|
... Great interview!! Keep up the hard work guys, for what you are doing for the shareholders. There is alot a bashers out there! The facts and the truth always win!! |
|
James Riehl
said:
|
... Thanks for taking the time to provide such a positive interview. I am sure a lot of investors appreciated this. I hope one day soon we will all see the benefits of this company: Hemispherx |
|
M.E.Garza
said:
|
... Thank you. I'm glad that you recognize our efforts and the efforts of truth seekers like Mr. Adams. Our goal is definitely to ask the question you want asked and seek the answers you want answers to as investors. Please keep giving us your feedback. |
|
PeterStock
said:
|
... Why does HEB not doing any PR on anything since it must have known that the dealy of Ampligen's approval and the silence of HEB have caused investors/traders to think/say negatively about HEB? It does not make sense that we need to get any information thru non-company personnels or websites. I believe all investors/traders just simply want a definite DAILY response/message from HEB directly about the Ampligen's situation. It does not really matter whether FDA has not provided any good or bad news to HEB yet. The main thing is we (investors/traders) want to know whether HEB has received any news from FDA daily. There is no excuse for HEB not to publish such info about the ongoing status of Ampligen and any newsworthy events such as addition to Russell index at least on its own website. |
|
Write comment
Sign Up For Phone Alerts
